LiveHealth+: 🇪🇺 Europe: Gavi Study Decodes the Fading Threat of Feared 'Subcl…

Posted by LiveHealth+ on LiveHealth+

🇪🇺 Europe: Gavi Study Decodes the Fading Threat of Feared 'Subclade K' Flu Strain A comprehensive global blood serum study published today has finally eased European public health anxieties regarding a highly mutated influenza strain that emerged late last year. The Concern: The H3N2 "subclade K" variant had accumulated rapid genetic mutations in the Southern Hemisphere, sparking fears that the Northern Hemisphere's upcoming winter flu vaccines would offer zero protection. The Finding: High-throughput immunity mapping proved that existing population antibodies and current vaccine compositions retain robust cross-reactivity against the variant, effectively downgrading its status from a potential pandemic threat to a manageable seasonal strain. Source: Gavi Vaccines Work Research Review